课题基金 / 基金详情

ACTG300--ZDV/3TC VS DDI MONOTHERAPY VS ZDV + DDI IN HIV INFECTED CHILDREN

ACTG300--ZDV/3TC VS DDI MONOTHERAPY VS ZDV + DDI IN HIV INFECTED CHILDREN
ACTG300--ZDV/3TC 与 DDI 单药疗法与 ZDV DDI 在 HIV 感染儿童中的比较
批准号:
6278078
负责人:
RICHARD RUTSTEIN
金额:
$2.4万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-12-01 至 1998-11-30

项目摘要

项目成果

RICHARD RUTSTEIN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Six patients have been enrolled at CHOP into this randomized, double- blind, comparative antiretroviral study. Originally, this study compared treatment with Zidovudine (ZDV) plus Lamivudine (3TC) versus ZDV plus ddI versus ddI monotherapy in HIV-infected children. Based on data from another ACTG study (ACTG 152), randomization to combination therapy with ZDV plus ddI ceased in June, 1996. This study had closed to enrollment of patients and all patients have completed study treatment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
STUDY OF BMS-232632 IN COMBINATION REGIMENS IN ANTIRETROVIRAL THERAPY
  • 批准号:
    7207692
  • 项目类别:
  • 资助金额:
    $3.56万
  • 财政年份:
    2005
  • 负责人:
    RICHARD RUTSTEIN
  • 依托单位:
PACTG 326: ALVAC HIV VACCINES AND AIDSVAX B/B IN CHILDREN BORN TO HIV MOTHERS
  • 批准号:
    7207785
  • 项目类别:
  • 资助金额:
    $1.1万
  • 财政年份:
    2005
  • 负责人:
    RICHARD RUTSTEIN
  • 依托单位:
PACTG 326: ALVAC HIV VACCINES AND AIDSVAX B/B IN CHILDREN BORN TO HIV MOTHERS
  • 批准号:
    7041890
  • 项目类别:
  • 资助金额:
    $2.12万
  • 财政年份:
    2004
  • 负责人:
    RICHARD RUTSTEIN
  • 依托单位:
STUDY OF BMS-232632 IN COMBINATION REGIMENS IN ANTIRETROVIRAL THERAPY
  • 批准号:
    7041819
  • 项目类别:
  • 资助金额:
    $4.2万
  • 财政年份:
    2004
  • 负责人:
    RICHARD RUTSTEIN
  • 依托单位:
海外基金